ARL2BP and gastric cancer: In our study, we overexpressed and knocked down BART19-3p expression in both EBV negative and EBV positive gastric cancer cells, and the results showed that BART1 greatly endorses tumor proliferation both in vitro and in vivo by affecting cell cycle.